sq-11725 has been researched along with clenbuterol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Benson, DW; Chance, WT; Fischer, JE; Foley-Nelson, T; James, JH; Zhang, FS | 1 |
| Benson, D; Chance, WT; Fischer, JE; von Allmen, D; Zhang, FS | 1 |
| Frampton, SF; Geyer, MA | 1 |
| Bray, GA; Nagase, H; Yamashita, J; York, DA | 1 |
| Horinouchi, T; Koike, K | 1 |
| Batchelor, HN; Bidlack, JM; Brown, E; Dawes, RP; Lordy, KA; Majewska, AK; Sipe, GO; Stoessel, MB; Stowell, RD; Sur, M; Whitelaw, BS | 1 |
8 other study(ies) available for sq-11725 and clenbuterol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Decreased myofibrillar protein breakdown following treatment with clenbuterol.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Clenbuterol; Eating; Male; Methylhistidines; Muscle Proteins; Muscles; Myofibrils; Nadolol; Rats; Rats, Inbred F344 | 1991 |
Clenbuterol decreases catabolism and increases hypermetabolism in burned rats.
Topics: Amino Acids; Animals; Body Weight; Burns; Clenbuterol; Drinking; Eating; Energy Metabolism; Muscles; Nadolol; Organ Size; Rats; Rats, Inbred Strains | 1991 |
Peripheral mediation of effects of clenbuterol on locomotor and investigatory behavior in rats.
Topics: Animals; Behavior, Animal; Clenbuterol; Drug Interactions; Ethanolamines; Exploratory Behavior; Isoproterenol; Locomotion; Male; Nadolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1988 |
Effects of clenbuterol, a beta 2-adrenoceptor agonist, on macronutrient selection in rats.
Topics: Afferent Pathways; Animals; Circadian Rhythm; Clenbuterol; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Food Preferences; Hunger; Liver; Male; Nadolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Vagus Nerve | 1994 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex.
Topics: Animals; Benzylamines; Cell Movement; Circadian Rhythm; Clenbuterol; CX3C Chemokine Receptor 1; Dexmedetomidine; Dominance, Ocular; Female; Fentanyl; Locus Coeruleus; Male; Mice; Mice, Transgenic; Microglia; Nadolol; Neuronal Plasticity; Neurons; Norepinephrine; Propanolamines; Restraint, Physical; Terbutaline; Visual Cortex; Wakefulness; Wounds and Injuries | 2019 |